Medical Supply – Lactated Ringer’s Injection

The contract is for the supply of sterile Ringer’s Injection, Lactated, identified by NSN 6505014623025, a commercially available intravenous fluid product intended for medical use. The product must meet all regulatory standards set by the FDA, the Defense Logistics Agency, and the Berry Amendment, ensuring it qualifies for government procurement and complies with U.S. manufacturing and sourcing requirements. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance expected to be carried out at Fort Campbell, Tennessee, and the solicitation is open for responses until August 17, 2026. The NAICS code 325412 indicates the industry category as Pharmaceutical and Medicine Manufacturing, aligning the supplier with established medical product production benchmarks. The opportunity is accessible via the DIBBS platform, and all participants must adhere to the specified compliance and delivery criteria to be considered eligible.